Article Information
History
- November 27, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Jennifer E. Sager1,*,
- Asma El-Zailik1,
- Julie Passarell2,
- Stefan Roepcke2,
- Xiaobin Li3,
- Melissa Aldinger1,
- Ahmed Nader3,
- Andrew Skingsley4,
- Elizabeth L. Alexander1,
- Wendy W. Yeh1,
- Erik Mogalian1,
- Chad Garner1,
- Amanda Peppercorn5,
- Adrienne E. Shapiro6 and
- Maribel Reyes1
- 1Vir Biotechnology, Inc., San Francisco, CA, USA
- 2Cognigen Division, Simulations Plus, Inc., Buffalo, NY, USA
- 3GSK, Upper Providence, PA, USA
- 4GSK, Brentford, UK
- 5GSK, Cambridge, Massachusetts, USA
- 6Fred Hutchinson Cancer Center, Seattle, WA, USA
- ↵*Author for correspondence:
Jennifer E. Sager, PhD, Vir Biotechnology, Inc., 499 Illinois Street, 5th Floor, San Francisco, CA, USA 94158, Tel: +1 415 987 5245, Email: jsager{at}vir.bio